ORMP vs. FMST
ORMP (Oramed Pharmaceuticals Inc.) and FMST (Foremost Lithium Resource & Technology Ltd. Common stock) are both stocks. ORMP operates in Biotechnology (Healthcare), while FMST operates in Chemicals (Basic Materials). Over the past year, ORMP returned 111.99% vs -55.23% for FMST. At a 0.10 correlation, their price movements are largely independent.
Performance
ORMP vs. FMST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ORMP achieves a 56.95% return, which is significantly higher than FMST's -27.36% return.
ORMP
- 1D
- 3.99%
- 1M
- 4.51%
- YTD
- 56.95%
- 6M
- 51.63%
- 1Y
- 111.99%
- 3Y*
- 11.23%
- 5Y*
- -20.56%
- 10Y*
- -5.81%
FMST
- 1D
- -0.65%
- 1M
- -4.94%
- YTD
- -27.36%
- 6M
- -36.63%
- 1Y
- -55.23%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ORMP vs. FMST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ORMP Oramed Pharmaceuticals Inc. | 56.95% | 29.55% |
FMST Foremost Lithium Resource & Technology Ltd. Common stock | -27.36% | 37.66% |
Correlation
The correlation between ORMP and FMST is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.10 |
The correlation between ORMP and FMST shifts across timeframes, from 0.10 (all time) to 0.21 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ORMP:
$175.02M
FMST:
$22.11M
ORMP:
$2.86
FMST:
-CA$0.27
ORMP:
0.73
FMST:
0.91
ORMP:
$0.00
FMST:
CA$0.00
ORMP:
$0.00
FMST:
CA$0.00
ORMP:
$67.00M
FMST:
-CA$3.43M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ORMP vs. FMST — Risk / Return Rank
ORMP
FMST
ORMP vs. FMST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oramed Pharmaceuticals Inc. (ORMP) and Foremost Lithium Resource & Technology Ltd. Common stock (FMST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ORMP | FMST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.76 | ||
| Sortino ratioReturn per unit of downside risk | +3.49 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 0.94 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 4.71 | -0.83 | +5.55 |
| Martin ratioReturn relative to average drawdown | 12.20 | -1.27 | +13.47 |
Loading charts...
Drawdowns
ORMP vs. FMST - Drawdown Comparison
The maximum ORMP drawdown since its inception was -94.25%, which is greater than FMST's maximum drawdown of -73.43%. Use the drawdown chart below to compare losses from any high point for ORMP and FMST.
Loading charts...
Drawdown Indicators
| ORMP | FMST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -73.43% | -20.82% |
Max Drawdown (1Y)Largest decline over 1 year | -23.89% | -66.51% | +42.62% |
Max Drawdown (3Y)Largest decline over 3 years | -52.63% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -94.25% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -94.25% | — | — |
Current DrawdownCurrent decline from peak | -84.96% | -71.59% | -13.37% |
Average DrawdownAverage peak-to-trough decline | -70.78% | -49.24% | -21.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.21% | 43.49% | -34.28% |
Volatility
ORMP vs. FMST - Volatility Comparison
The current volatility for Oramed Pharmaceuticals Inc. (ORMP) is 15.66%, while Foremost Lithium Resource & Technology Ltd. Common stock (FMST) has a volatility of 21.06%. This indicates that ORMP experiences smaller price fluctuations and is considered to be less risky than FMST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ORMP | FMST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.66% | 21.06% | -5.40% |
Volatility (6M)Calculated over the trailing 6-month period | 39.15% | 58.73% | -19.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.53% | 96.37% | -44.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.05% | 119.95% | -38.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.94% | 119.95% | -48.01% |
Dividends
ORMP vs. FMST - Dividend Comparison
ORMP's dividend yield for the trailing twelve months is around 6.00%, while FMST has not paid dividends to shareholders.
| Position | TTM |
|---|---|
FMST Foremost Lithium Resource & Technology Ltd. Common stock | 0.00% |
ORMP Oramed Pharmaceuticals Inc. | 6.00% |
Financials
ORMP vs. FMST - Financials Comparison
This section allows you to compare key financial metrics between Oramed Pharmaceuticals Inc. and Foremost Lithium Resource & Technology Ltd. Common stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ORMP and FMST have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FMST has higher volatility (21.06%) compared to ORMP (15.66%). In terms of maximum drawdown, ORMP dropped -94.25% vs FMST's -73.43%.
ORMP currently has the higher Sharpe Ratio (2.19 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ORMP and FMST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer